CollPlant Biotechnologies (CLGN) Change in Account Payables (2020 - 2026)
CollPlant Biotechnologies (CLGN) reported Change in Account Payables of $25000.0 for Q1 2026, up 125.0% on a YoY basis from $11111.1 in Q1 2025, and up 412.5% quarter-over-quarter from -$8000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Change in Account Payables (2020 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Change in Account Payables for 7 years, with the latest figure at $25000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 125.0% year-over-year to $25000.0; the trailing twelve-month figure through Mar 2026 stood at -$135000.0 (up 61.32% YoY), and the FY2025 full-year result was -$260000.0, down 136.36% from the prior year.
- Change in Account Payables for Q1 2026 stood at $25000.0, up from -$8000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $253000.0 in Q4 2022, with the low at -$248000.0 in Q1 2023.
- Historically, Change in Account Payables has averaged -$23470.6 across 5 years, with a median of -$19000.0 in 2023.
- Annual changes were most pronounced in 2024 — Change in Account Payables surged 156.05% — and 2025, when it plunged 1147.37%.
- CollPlant Biotechnologies' Change in Account Payables stood at $253000.0 in 2022, then slipped by 6.72% to $236000.0 in 2023, then plunged by 158.9% to -$139000.0 in 2024, then jumped by 94.24% to -$8000.0 in 2025, then surged by 412.5% to $25000.0 in 2026.
- The last three Change in Account Payables figures came in at $25000.0 (Q1 2026), -$8000.0 (Q4 2025), and $47000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -9.42 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | -199,000.00 |
| Jun 30, 2025 | -199,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -139,000.00 |
| Dec 31, 2024 | -139,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Dec 31, 2023 | 236,000.00 |
| Dec 31, 2023 | 236,000.00 |